Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9289)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 10, 2016 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Endoscopy
ISSN
1948-5190
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Viterbo D, Gausman V, Gonda T. Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy. World J Gastrointest Endosc 2016; 8(3): 128-142 [PMID: 26862363 DOI: 10.4253/wjge.v8.i3.128] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v8/i3/128.htm |
| Number | Citing Articles |
| 1 |
Alexander Ney, Andres Garcia-Sampedro, George Goodchild, Pilar Acedo, Giuseppe Fusai, Stephen P. Pereira. Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699401
|
| 2 |
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky, A. V. Chzhao. Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review). Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2019; 23(4): 108 doi: 10.16931/1995-5464.20184108-117
|
| 3 |
Daniele Dondossola, Michele Ghidini, Francesco Grossi, Giorgio Rossi, Diego Foschi. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World Journal of Gastroenterology 2020; 26(25): 3542-3561 doi: 10.3748/wjg.v26.i25.3542
|
| 4 |
Zeeshan Sattar, Saeed Ali, Ishtiaq Hussain, Farhan Sattar, Sana Hussain, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 51 doi: 10.1016/B978-0-12-819457-7.00002-5
|
| 5 |
Didi Liu, Jun Li, Yue Xue, Ting Zhao, Zhehui Jin, Wei Dan, Zexuan Chen, Liangshuo Hu, Shisheng Sun. Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma. International Journal of Biological Macromolecules 2024; 280: 135563 doi: 10.1016/j.ijbiomac.2024.135563
|
| 6 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
|
| 7 |
Jérôme Raffenne, Jérôme Cros. La caractérisation moléculaire définit plusieurs sous-types d’adénocarcinome canalaire du pancréas. Bulletin du Cancer 2018; 105(1): 55 doi: 10.1016/j.bulcan.2017.11.010
|
| 8 |
Hongyu Xie, Yan Hou, Jinlong Cheng, Margarita S. Openkova, Bairong Xia, Wenjie Wang, Ang Li, Kai Yang, Junnan Li, Huan Xu, Chunyan Yang, Libing Ma, Zhenzi Li, Xin Fan, Kang Li, Ge Lou. Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer. Oncotarget 2017; 8(19): 32134 doi: 10.18632/oncotarget.16739
|
| 9 |
George Georgiadis, Charalampos Belantis, Charalampos Mamoulakis, John Tsiaoussis, Wallace A. Hayes, Aristidis M. Tsatsakis. Biomarkers in Toxicology. 2019; : 855 doi: 10.1016/B978-0-12-814655-2.00047-5
|
| 10 |
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, Claudia Cinque, Stefania Farace, Renato Patrone, Vincenza Granata, Andrea Zovi, Guglielmo Nasti, Alessandro Ottaiano. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments. Molecular and Cellular Probes 2024; 73: 101951 doi: 10.1016/j.mcp.2024.101951
|
| 11 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
|
| 12 |
Steven Alexander Mann, Romil Saxena. Predictive Biomarkers in Oncology. 2019; : 437 doi: 10.1007/978-3-319-95228-4_40
|
| 13 |
Ying Yang, Shirong Yan, Hui Tian, Yixi Bao. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19–9 as a biomarker for diagnosis of pancreatic cancer. Medicine 2018; 97(9): e9994 doi: 10.1097/MD.0000000000009994
|
| 14 |
F. Rassam, E. Roos, K. P. van Lienden, J. E. van Hooft, H. J. Klümpen, G. van Tienhoven, R. J. Bennink, M. R. Engelbrecht, A. Schoorlemmer, U. H. W. Beuers, J. Verheij, M. G. Besselink, O. R. Busch, T. M. van Gulik. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbeck's Archives of Surgery 2018; 403(3): 289 doi: 10.1007/s00423-018-1649-2
|
| 15 |
|
| 16 |
Sven H. Loosen, Christoph Roderburg, Katja L. Kauertz, Alexander Koch, Mihael Vucur, Anne T. Schneider, Marcel Binnebösel, Tom F. Ulmer, Georg Lurje, Wenzel Schoening, Frank Tacke, Christian Trautwein, Thomas Longerich, Cornelis H. Dejong, Ulf P. Neumann, Tom Luedde. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17175-7
|
| 17 |
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinoma. Critical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015
|